Daniel Iazzetti - Angion Biomedica VP HR
| ANGNDelisted Stock | USD 10.00 8.94 843.40% |
Insider
Daniel Iazzetti is VP HR of Angion Biomedica Corp
| Phone | 415 655 4899 |
| Web | https://www.angion.com |
Angion Biomedica Management Efficiency
The company has return on total asset (ROA) of (0.2089) % which means that it has lost $0.2089 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5447) %, meaning that it created substantial loss on money invested by shareholders. Angion Biomedica's management efficiency ratios could be used to measure how well Angion Biomedica manages its routine affairs as well as how well it operates its assets and liabilities.Angion Biomedica Corp currently holds 4.2 M in liabilities with Debt to Equity (D/E) ratio of 0.07, which may suggest the company is not taking enough advantage from borrowing. Angion Biomedica Corp has a current ratio of 8.3, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Angion Biomedica's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Martina BS | Pyxis Oncology | 59 | |
| RPh PharmD | Elevation Oncology | 40 | |
| JD MBA | Immix Biopharma | N/A | |
| Marcel CPA | Altamira Therapeutics | 66 | |
| Ryan Bloomer | Elevation Oncology | N/A | |
| LaBella MS | ZyVersa Therapeutics | 66 | |
| John CPA | Unicycive Therapeutics | 62 | |
| MPA MD | Unicycive Therapeutics | 51 | |
| MD FAAAAI | Palisade Bio | N/A | |
| Brian Sullivan | Elevation Oncology | N/A | |
| DSc MSE | Immix Biopharma | 75 | |
| Valerie MD | Elevation Oncology | 46 | |
| Joseph Ferra | Elevation Oncology | 49 | |
| Karen Cashmere | ZyVersa Therapeutics | 72 | |
| Balu Balasubramanian | Pyxis Oncology | N/A | |
| Robert McRae | Palisade Bio | N/A | |
| Jean Lechance | Altamira Therapeutics | N/A | |
| Samuel MD | Altamira Therapeutics | 71 | |
| Gabriel BA | Immix Biopharma | 37 | |
| Jan Pinkas | Pyxis Oncology | N/A | |
| Pamela MBA | Pyxis Oncology | 62 | |
Management Performance
| Return On Equity | -0.54 | |||
| Return On Asset | -0.21 |
Angion Biomedica Corp Leadership Team
Elected by the shareholders, the Angion Biomedica's board of directors comprises two types of representatives: Angion Biomedica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Angion. The board's role is to monitor Angion Biomedica's management team and ensure that shareholders' interests are well served. Angion Biomedica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Angion Biomedica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel Iazzetti, VP HR | ||
| Jennifer JD, Chief VP | ||
| Bruce Rich, Assistant Sec | ||
| Gregory Curhan, Chief Officer | ||
| MBA MD, CEO Pres |
Angion Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Angion Biomedica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.54 | |||
| Return On Asset | -0.21 | |||
| Operating Margin | (31.48) % | |||
| Current Valuation | (26.79 M) | |||
| Shares Outstanding | 30.11 M | |||
| Shares Owned By Insiders | 33.02 % | |||
| Shares Owned By Institutions | 16.36 % | |||
| Number Of Shares Shorted | 63.65 K | |||
| Price To Book | 0.49 X | |||
| Price To Sales | 0.90 X |
Pair Trading with Angion Biomedica
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Angion Biomedica position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Angion Biomedica will appreciate offsetting losses from the drop in the long position's value.Moving against Angion Stock
| 0.81 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.72 | NVO | Novo Nordisk AS | PairCorr |
| 0.71 | NONOF | Novo Nordisk AS | PairCorr |
| 0.71 | CSLLY | CSL | PairCorr |
| 0.71 | AULT | Ault Alliance Symbol Change | PairCorr |
The ability to find closely correlated positions to Angion Biomedica could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Angion Biomedica when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Angion Biomedica - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Angion Biomedica Corp to buy it.
The correlation of Angion Biomedica is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Angion Biomedica moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Angion Biomedica Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Angion Biomedica can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Angion Stock
If you are still planning to invest in Angion Biomedica Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Angion Biomedica's history and understand the potential risks before investing.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |